| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009417498 |
| P356 | DOI | 10.1007/S11926-013-0361-Z |
| P8608 | Fatcat ID | release_upp2wxlfwrfajnt2pgmf2tifj4 |
| P698 | PubMed publication ID | 23955063 |
| P5875 | ResearchGate publication ID | 255975413 |
| P50 | author | Yves Henrotin | Q59556277 |
| P2093 | author name string | Cécile Lambert | |
| P2860 | cites work | The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate | Q95305820 |
| Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? | Q21195259 | ||
| Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study | Q22000858 | ||
| Glucosamine therapy for treating osteoarthritis | Q24244026 | ||
| Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis | Q24606203 | ||
| Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system | Q24647595 | ||
| EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) | Q24674132 | ||
| Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats | Q24804396 | ||
| Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis | Q28374250 | ||
| EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | Q31119321 | ||
| Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo | Q33199633 | ||
| Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials | Q33214439 | ||
| EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | Q33260652 | ||
| OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence | Q33295110 | ||
| OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines | Q33320085 | ||
| OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. | Q33532831 | ||
| Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes | Q33631650 | ||
| The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination | Q33679221 | ||
| Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis | Q33993736 | ||
| Pharmacoproteomic study of three different chondroitin sulfate compounds on intracellular and extracellular human chondrocyte proteomes | Q34112904 | ||
| Osteoarthritis: a disease of the joint as an organ | Q34258870 | ||
| American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee | Q34273218 | ||
| Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis | Q34556616 | ||
| Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. | Q34581685 | ||
| The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes--implications for osteoarthritis | Q34626232 | ||
| Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities | Q34636799 | ||
| Glucosamine for pain in osteoarthritis: why do trial results differ? | Q34643259 | ||
| Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI | Q34906145 | ||
| Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine | Q35092924 | ||
| Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness | Q35636751 | ||
| Fursultiamine, a vitamin B1 derivative, enhances chondroprotective effects of glucosamine hydrochloride and chondroitin sulfate in rabbit experimental osteoarthritis | Q46562451 | ||
| Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice | Q46576967 | ||
| Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways | Q46702331 | ||
| Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial | Q46746770 | ||
| Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants | Q46840579 | ||
| Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes | Q46914099 | ||
| Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA/1J mice | Q47432573 | ||
| Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters | Q47772513 | ||
| Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions. | Q50963656 | ||
| Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs. | Q51392424 | ||
| Effects of chondroitin sulfate-C on articular cartilage destruction in murine collagen-induced arthritis. | Q51411662 | ||
| Chondroitin sulphate: an effective joint lubricant? | Q52849945 | ||
| Chondroitin sulfate and hyaluronic acid (500-730 kda) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. | Q54764398 | ||
| The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis | Q80238410 | ||
| Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1beta-stimulated chondrocytes--study in hypoxic alginate bead cultures | Q80600333 | ||
| Natural chondroitin sulphates increase aggregation of proteoglycan complexes and decrease ADAMTS-5 expression in interleukin 1 beta-treated chondrocytes | Q81364057 | ||
| Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial | Q81484755 | ||
| Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes | Q82607594 | ||
| Assorted effects of TGFbeta and chondroitinsulfate on p38 and ERK1/2 activation levels in human articular chondrocytes stimulated with LPS | Q82668624 | ||
| Anti-arthritic action mechanisms of natural chondroitin sulfate in human articular chondrocytes and synovial fibroblasts | Q83069860 | ||
| Effects of glucosamine derivatives and uronic acids on the production of glycosaminoglycans by human synovial cells and chondrocytes | Q83760773 | ||
| Chondroitin sulfate effect on induced arthritis in rats | Q84872505 | ||
| Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center | Q84904549 | ||
| Urinary glycosaminoglycans in horse osteoarthritis. Effects of chondroitin sulfate and glucosamine | Q84957472 | ||
| Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. | Q36059429 | ||
| Osteoarthritis - an untreatable disease? | Q36085680 | ||
| Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate | Q36245717 | ||
| Chondroitin sulphate: antioxidant properties and beneficial effects | Q36683808 | ||
| Antioxidant activity of chondroitin sulfate | Q36713886 | ||
| Analytical aspects of pharmaceutical grade chondroitin sulfates. | Q36881374 | ||
| Osteoarthritis: a tale of three tissues. | Q37304243 | ||
| Immunomodulatory and anti-inflammatory effects of chondroitin sulphate | Q37310621 | ||
| The effects of oral glucosamine on joint health: is a change in research approach needed? | Q37592565 | ||
| Quality of different chondroitin sulfate preparations in relation to their therapeutic activity | Q37611121 | ||
| Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration | Q37732921 | ||
| Modulation of inflammation by chondroitin sulfate | Q37732933 | ||
| The glucosamine controversy; a pharmacokinetic issue. | Q37898236 | ||
| Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule | Q37951364 | ||
| Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence? | Q38062928 | ||
| Experimental pharmacology of glucosamine sulfate. | Q38684643 | ||
| Effect of glucosamine, a therapeutic agent for osteoarthritis, on osteoblastic cell differentiation | Q39549509 | ||
| Effects of sodium-hyaluronate and glucosamine-chondroitin sulfate on remodeling stage of tenotomized superficial digital flexor tendon in rabbits: a clinical, histopathological, ultrastructural, and biomechanical study. | Q39811721 | ||
| Differential down-regulation of COX-2 and MMP-13 in human skin fibroblasts by glucosamine-hydrochloride | Q39816519 | ||
| The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions | Q39859492 | ||
| Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial | Q39871697 | ||
| Suppression of cytokine production in lipopolysaccharide-stimulated mouse macrophages by novel cationic glucosamine derivative involves down-regulation of NF-kappaB and MAPK expressions | Q39940844 | ||
| Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappaB. | Q40144254 | ||
| Glucosamine sulfate promotes osteoblastic differentiation of MG-63 cells via anti-inflammatory effect | Q40175942 | ||
| Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties | Q42135777 | ||
| Glucosamine sulfate reduces prostaglandin E(2) production in osteoarthritic chondrocytes through inhibition of microsomal PGE synthase-1. | Q42723818 | ||
| Oral glucosamine increases expression of transforming growth factor β1 (TGFβ1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: implications for human efficacy and toxicity | Q42744063 | ||
| Glucosamine sulfate reduces experimental osteoarthritis and nociception in rats: association with changes of mitogen-activated protein kinase in chondrocytes | Q43051043 | ||
| Therapeutic efficacy of undenatured type-II collagen (UC-II) in comparison to glucosamine and chondroitin in arthritic horses | Q43073554 | ||
| Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model | Q43148053 | ||
| Variable effects of 3 different chondroitin sulfate compounds on human osteoarthritic cartilage/chondrocytes: relevance of purity and production process | Q43181477 | ||
| Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes | Q43267786 | ||
| Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis | Q43546528 | ||
| Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study | Q43775584 | ||
| Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits | Q44159772 | ||
| Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro. | Q44202194 | ||
| Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes | Q44394411 | ||
| Interpretation of metaanalyses: pitfalls should be more widely recognized | Q44625245 | ||
| A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. | Q44668477 | ||
| Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. | Q44896503 | ||
| Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt. | Q46106596 | ||
| Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis | Q46406275 | ||
| Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats | Q46481855 | ||
| P433 | issue | 10 | |
| P921 | main subject | osteoarthritis | Q62736 |
| glucosamine | Q32907954 | ||
| P304 | page(s) | 361 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Chondroitin and glucosamine in the management of osteoarthritis: an update | |
| P478 | volume | 15 |
| Q42292745 | A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine. |
| Q64115416 | A randomised pilot equivalence trial to evaluate diamagnetically enhanced transdermal delivery of key ground substance components in comparison to an established transdermal non-steroidal anti-inflammatory formulation in males with prior knee injury |
| Q34156091 | Angelica Sinensis polysaccharides stimulated UDP-sugar synthase genes through promoting gene expression of IGF-1 and IGF1R in chondrocytes: promoting anti-osteoarthritic activity |
| Q39539742 | Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Plac |
| Q36475626 | Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib |
| Q89282120 | Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials |
| Q35844016 | Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. |
| Q55332100 | Global transcriptome analysis to identify critical genes involved in the pathology of osteoarthritis. |
| Q52724784 | Glucosamine promotes chondrocyte proliferation via the Wnt/β‑catenin signaling pathway. |
| Q28550121 | Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract |
| Q34459643 | Management of Osteoarthritis with Avocado/Soybean Unsaponifiables. |
| Q56288810 | Osteoarthritis |
| Q38553080 | Review of dietary supplements for the management of osteoarthritis in dogs in studies from 2004 to 2014. |
| Q91651972 | The Immune Cell Landscape in Different Anatomical Structures of Knee in Osteoarthritis: A Gene Expression-Based Study |
Search more.